Vivo Capital’s Alpine Immune Sciences Inc ALPN Stock Holding History

Vivo Capital’s Portfolio ALPN Stock Details ALPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-520,505	Closed	-$20.8M	–	45
2024 Q1	$20.8M	Sell	520,505 -298,770	-36%	-$8.82M	1.63%	15
2023 Q4	$15.6M	Sell	819,275 -95,638	-10%	-$1.33M	1.28%	14
2023 Q3	$10.5M	Hold	914,913	–	–	1.15%	23
2023 Q2	$9.41M	Buy	+914,913	New	+$8.25M	0.65%	24

Vivo Capital's ALPN Position: Q2 2024 in Review

Vivo Capital sold out of Alpine Immune Sciences Inc (ALPN) in Q2 2024, closing a stake of 520,505 shares — an estimated $20.8M sold.

Vivo Capital first reported a position in ALPN in Q2 2023 and held it in 4 quarters. The position peaked at $20.8M in Q1 2024. 0 funds tracked by Wall St. Rank hold ALPN as of Q2 2024.

Vivo Capital reported no remaining Alpine Immune Sciences Inc position as of Q2 2024 after selling out during the quarter.
Vivo Capital sold 520,505 Alpine Immune Sciences Inc shares in Q2 2024, an estimated $20.8M.
Vivo Capital first reported a position in Alpine Immune Sciences Inc in Q2 2023 and held it in 4 quarters.
Vivo Capital's Alpine Immune Sciences Inc position peaked at $20.8M in Q1 2024.
0 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q2 2024.

Based on Vivo Capital's 13F filing for Q2 2024, filed 14 Aug 2024.